MobiHealth News June 24, 2025
Jessica Hagen

Julien Payen, cofounder and CEO of Lattice Medical, describes the company’s 3D-printed, resorbable breast implant that uses a patient’s own fat to regenerate natural breast tissue after a mastectomy.

Lattice Medical has created a 3D-printed, resorbable implant called MATTISSE, designed to use an oncology patient’s own fat tissue to regenerate one’s breast after undergoing a mastectomy.

Julien Payen, cofounder and CEO of Lattice Medical, sat down with MobiHealthNews to discuss the company’s innovative approach to breast reconstruction for cancer patients and how the technology works.

MobiHealthNews: What is Lattice Medical offering oncology patients?

Julien Payen: Lattice Medical is a company focusing on breast reconstruction after cancer. Breast cancer affects one in eight women in the world, and 30%...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: 3D Printing, Interview / Q&A, Technology, Trends
Related Articles:
Top 10 Moonshot Ideas for 3D Printing’s Future
3D Printing Predictions for 2026: Scaling AM Through Software
How 3D Printing is Making the World a Better Place, One Medical Innovation at a Time
Will Growth in Robotics Spawn More 3D Printing?
Who Merged, Who Was Acquired, and Who Disappeared in 3D Printing in 2025

Share Article